These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

226 related items for PubMed ID: 9469592

  • 1. Influence of the electrostatic charge of lipoprotein particles on the activity of the human plasma phospholipid transfer protein.
    Desrumaux C, Athias A, Masson D, Gambert P, Lallemant C, Lagrost L.
    J Lipid Res; 1998 Jan; 39(1):131-42. PubMed ID: 9469592
    [Abstract] [Full Text] [Related]

  • 2. Opposite effects of cholesteryl ester transfer protein and phospholipid transfer protein on the size distribution of plasma high density lipoproteins. Physiological relevance in alcoholic patients.
    Lagrost L, Athias A, Herbeth B, Guyard-Dangremont V, Artur Y, Paille F, Gambert P, Lallemant C.
    J Biol Chem; 1996 Aug 09; 271(32):19058-65. PubMed ID: 8702577
    [Abstract] [Full Text] [Related]

  • 3. Evidence for electronegativity of plasma high density lipoprotein-3 as one major determinant of human cholesteryl ester transfer protein activity.
    Masson D, Athias A, Lagrost L.
    J Lipid Res; 1996 Jul 09; 37(7):1579-90. PubMed ID: 8827528
    [Abstract] [Full Text] [Related]

  • 4. Plasma phospholipid mass transfer rate: relationship to plasma phospholipid and cholesteryl ester transfer activities and lipid parameters.
    Cheung MC, Wolfbauer G, Albers JJ.
    Biochim Biophys Acta; 1996 Sep 27; 1303(2):103-10. PubMed ID: 8856039
    [Abstract] [Full Text] [Related]

  • 5. Evaluation of phospholipid transfer protein and cholesteryl ester transfer protein as contributors to the generation of pre beta-high-density lipoproteins.
    Lie J, de Crom R, Jauhiainen M, van Gent T, van Haperen R, Scheek L, Jansen H, Ehnholm C, van Tol A.
    Biochem J; 2001 Dec 01; 360(Pt 2):379-85. PubMed ID: 11716766
    [Abstract] [Full Text] [Related]

  • 6. Phospholipid transfer protein gene knock-out mice have low high density lipoprotein levels, due to hypercatabolism, and accumulate apoA-IV-rich lamellar lipoproteins.
    Qin S, Kawano K, Bruce C, Lin M, Bisgaier C, Tall AR, Jiang X.
    J Lipid Res; 2000 Feb 01; 41(2):269-76. PubMed ID: 10681411
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The mechanism of human plasma phospholipid transfer protein-induced enlargement of high-density lipoprotein particles: evidence for particle fusion.
    Lusa S, Jauhiainen M, Metso J, Somerharju P, Ehnholm C.
    Biochem J; 1996 Jan 01; 313 ( Pt 1)(Pt 1):275-82. PubMed ID: 8546695
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Roles of plasma lipid transfer proteins in reverse cholesterol transport.
    Yamashita S, Sakai N, Hirano K, Ishigami M, Maruyama T, Nakajima N, Matsuzawa Y.
    Front Biosci; 2001 Mar 01; 6():D366-87. PubMed ID: 11229884
    [Abstract] [Full Text] [Related]

  • 11. Distribution of phospholipid transfer protein in human plasma: presence of two forms of phospholipid transfer protein, one catalytically active and the other inactive.
    Oka T, Kujiraoka T, Ito M, Egashira T, Takahashi S, Nanjee MN, Miller NE, Metso J, Olkkonen VM, Ehnholm C, Jauhiainen M, Hattori H.
    J Lipid Res; 2000 Oct 01; 41(10):1651-7. PubMed ID: 11013307
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Elevated plasma cholesteryl ester transfer in NIDDM: relationships with apolipoprotein B-containing lipoproteins and phospholipid transfer protein.
    Riemens S, van Tol A, Sluiter W, Dullaart R.
    Atherosclerosis; 1998 Sep 01; 140(1):71-9. PubMed ID: 9733217
    [Abstract] [Full Text] [Related]

  • 15. Postprandial variations in the cholesteryl ester transfer protein activity, phospholipid transfer protein activity and plasma cholesterol efflux capacity in normolipidemic men.
    Syeda F, Senault C, Delplanque B, Le Roy B, Thaminy A, Gripois D, Blouquit MF, Ruelland A, Mendy F, Lutton C.
    Nutr Metab Cardiovasc Dis; 2003 Feb 01; 13(1):28-36. PubMed ID: 12772435
    [Abstract] [Full Text] [Related]

  • 16. Plasma lipoprotein distribution and lipid transfer activities in patients with type IIb hyperlipidemia treated with simvastatin.
    Lagrost L, Athias A, Lemort N, Richard JL, Desrumaux C, Châtenet-Duchêne L, Courtois M, Farnier M, Jacotot B, Braschi S, Gambert P.
    Atherosclerosis; 1999 Apr 01; 143(2):415-25. PubMed ID: 10217372
    [Abstract] [Full Text] [Related]

  • 17. The role of plasma phospholipid transfer protein (PLTP) in HDL remodeling in acute-phase patients.
    Pussinen PJ, Metso J, Malle E, Barlage S, Palosuo T, Sattler W, Schmitz G, Jauhiainen M.
    Biochim Biophys Acta; 2001 Sep 28; 1533(2):153-63. PubMed ID: 11566452
    [Abstract] [Full Text] [Related]

  • 18. Targeted mutation of plasma phospholipid transfer protein gene markedly reduces high-density lipoprotein levels.
    Jiang XC, Bruce C, Mar J, Lin M, Ji Y, Francone OL, Tall AR.
    J Clin Invest; 1999 Mar 28; 103(6):907-14. PubMed ID: 10079112
    [Abstract] [Full Text] [Related]

  • 19. Triglyceride-enrichment of high density lipoproteins enhances their remodelling by phospholipid transfer protein.
    Rye KA, Jauhiainen M, Barter PJ, Ehnholm C.
    J Lipid Res; 1998 Mar 28; 39(3):613-22. PubMed ID: 9548593
    [Abstract] [Full Text] [Related]

  • 20. Relationship between plasma phospholipid transfer protein activity and HDL subclasses among patients with low HDL and cardiovascular disease.
    Cheung MC, Wolfbauer G, Brown BG, Albers JJ.
    Atherosclerosis; 1999 Jan 28; 142(1):201-5. PubMed ID: 9920522
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.